Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases

Bone Marrow Transplantation

Volumn 23, Issue 6, 1999, Pages 533-537

  Alessandrino, E P ^a,c   Bernasconi, P ^a   Caldera, D ^a   Colombo, A ^a   Bonfichi, M ^a   Malcovati, L ^a   Klersy, C ^b   Martinelli, G ^a   Maiocchi, M ^a   Pagnucco, G ^a   Varettoni, M ^a   Perotti, C ^c   Bernasconi, C ^a  

^a Istituto di Ematologia   (Italy)

^b Biometry Scientific Direction   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Bone marrow transplantation; Bradycardia; Cryopreservation; DMSO; Peripheral blood progenitor cell transplantation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BRADYCARDIA; CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CONTAMINATION; CRYOPRESERVATION; ERYTHROCYTE; FEMALE; HEART BLOCK; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA; HUMAN; HUMAN CELL; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0033021721     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701609     Document Type: Article

References (20)

1. Cheson BD, Lacerna L, Leyland-Jones B et al. Autologous bone marrow transplantation: current status and future directions. Ann Intern Med 1989; 110: 51-65.
2. Spitzer G. Autotransplantation in solid tumours. Blood Rev 1991; 5: 105-111.
3. Gorin NC. Collection manipulation and freezing of haemopoietic stem cells. Clin Haematol 1986; 15: 19-49.
4. Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992; 1: 223-250.
5. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryo-preservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990; 5 (Suppl. 1): 25-27.
6. Stroncek DF, Fautsch SK, Lasky LC et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521-526.
7. Kessinger A, Armitage JO, Smith DM et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260-1265.
8. Davis JM, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781-786.
9. Lopez-Jimenez J, Cervero C, Munoz A et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994; 13: 789-793.
10. Keung Y-K, Lau S, Elkayam U et al. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994; 14: 363-367.
11. Rapaport AP, Rowe JM, Packman CH, Ginsberg SJ. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991; 7: 401-403.
12. Styler MJ, Topolsky DL, Crilley PA et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992; 10: 435-438.
13. Besinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3163.
14. Ager S, Mahendra P, Richards EM et al. High dose carmustine, etoposide and melphalan (BEM) with autologous stem cell transplantation: a dose toxicity study. Bone Marrow Transplant 1996; 17: 335-340.
15. Shpall EJ, LeMaistre CF, Holland K et al. A prospective randomised trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high dose chemotherapy. Blood 1997; 90: 4313-4320.
16. Shlafer M, Karow AM. Pharmacological effects of dimethyl-sulfoxide on the mammalian myocardium. Ann NY Acad Sci 1975; 243: 110-121.
17. Kligman AM. Topical pharmacology and toxicology of dimethyl sulfoxide - part 1. JAMA 1965; 193: 140-148.
18. Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12: 998-1004.
19. Sculier JP, Coune A, Klastersky J. Transient heart block an unreported toxicity of high dose chemotherapy with cyclophosphamide and etoposide. Acta Clin Belg 1985; 40: 112-114.
20. Cazin B, Gorin NC, LaPorte JP et al. Cardiac complications after bone marrow transplantation. Cancer 1986; 57: 2061-2069.